PET scans with carbon 11 (11C)–labeled Pittsburgh compound B were performed by using a GE scanner (Advance PET; GE Healthcare, Milwaukee, Wis) in a subset of 119 study participants (Table 2 ). Distribution volume ratio images were generated by using a method reported by Bilgel et al (23 (link)). Mean cortical distribution volume ratio was calculated as an index of cortical 11C Pittsburgh compound B retention to quantify amyloid accumulation (see Appendix E1 [online]).
Advance pet
Manufactured by GE Healthcare
Sourced in United States
The Advance PET is a positron emission tomography (PET) imaging system developed by GE Healthcare. It is designed for high-performance PET imaging, providing accurate and reliable data for medical applications.
Automatically generated - may contain errors
Lab products found in correlation
3 protocols using advance pet
1
Quantifying Amyloid Accumulation with 11C-PiB PET
2
PET Amyloid Imaging Protocol Qualification
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Site PET scanners were qualified with a Hoffman brain phantom. PET amyloid imaging was performed as part of study AV45-A05.25 (link) Fifty minutes after intravenous injection of 10 mCi (370 MBq) of florbetapir F 18, a 10-min emission scan (acquired in 2 × 5 min frames) was obtained. PET scanners included Discovery LS PET/CT (GE, Fairfield, CT, USA), Advance PET (GE), ECAT HR+ (Siemens, Washington DC, USA) and Biograph PET/CT (Siemens) models. Image reconstruction utilized an iterative algorithm (4 iterations, 16 subsets) and a post reconstruction Gaussian filter of 5 mm.
Three nuclear medicine physicians, blinded to clinical data, independently rated the PET images at an imaging core lab (ICON Medical Imaging, Warrington, PA, USA). A binary qualitative scale (amyloid positive: Aβ+ or amyloid negative: Aβ−) was implemented in this study according to the pattern of tracer uptake observed in cortical gray matter areas. The PET rating methods, visual rater training and reliability have been described previously.22 (link),25 (link),27 (link) In brief, scans were rated as amyloid negative if tracer retention was seen predominantly in white matter, with no appreciable or low levels of tracer retention in cortical gray matter. Scans were rated as amyloid positive when tracer showed a gray matter pattern of distribution with accumulation along the midline and surface of the cortex.
Three nuclear medicine physicians, blinded to clinical data, independently rated the PET images at an imaging core lab (ICON Medical Imaging, Warrington, PA, USA). A binary qualitative scale (amyloid positive: Aβ+ or amyloid negative: Aβ−) was implemented in this study according to the pattern of tracer uptake observed in cortical gray matter areas. The PET rating methods, visual rater training and reliability have been described previously.22 (link),25 (link),27 (link) In brief, scans were rated as amyloid negative if tracer retention was seen predominantly in white matter, with no appreciable or low levels of tracer retention in cortical gray matter. Scans were rated as amyloid positive when tracer showed a gray matter pattern of distribution with accumulation along the midline and surface of the cortex.
3
PET Imaging for Endocrine Therapy Evaluation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!